MedPath

A Clinical study to see the effect of Unani medicine Sharbat Sadar in Surfa YÄ?bis (Dry Cough)

Phase 3
Conditions
Health Condition 1: R05- CoughHealth Condition 2: null- Surfa YÄ?bis (Dry Cough)
Registration Number
CTRI/2018/10/016177
Lead Sponsor
Central Council for Research in Unani Medicine
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
300
Inclusion Criteria

1. Patients of either sex in the age group of 18-60

2. Surfa YÄ?bis (Dry Cough) of < 3 weeks duration

Exclusion Criteria

1. Upper respiratory tract Infections having productive cough.

2. Lower Respiratory Tract Infections (LRI or LRTI) including pneumonia, lung abscess, and acute bronchitis.

3. Chronic obstructive airway disease (COAD) including chronic bronchitis and emphysema.

4. Bronchiectasis, pulmonary tuberculosis, pulmonary oedema, interstitial pulmonary fibrosis

5. Tumours of larynx, bronchi, and lungs

6. High Grade Fever > 101oF

7. Drug-induced Cough (e.g., ACE Inhibitors)

8. Diabetes Mellitus, Hypertension

9. Known cases of severe hepatic, renal or cardiac ailments

10. H/o addiction (smoking, alcohol, drugs)

11. Pregnant and lactating women

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath